Literature DB >> 19172649

Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Jonathan H Morra1, Zhuowen Tu, Liana G Apostolova, Amity E Green, Christina Avedissian, Sarah K Madsen, Neelroop Parikshak, Xue Hua, Arthur W Toga, Clifford R Jack, Norbert Schuff, Michael W Weiner, Paul M Thompson.   

Abstract

We used a new method we developed for automated hippocampal segmentation, called the auto context model, to analyze brain MRI scans of 400 subjects from the Alzheimer's disease neuroimaging initiative. After training the classifier on 21 hand-labeled expert segmentations, we created binary maps of the hippocampus for three age- and sex-matched groups: 100 subjects with Alzheimer's disease (AD), 200 with mild cognitive impairment (MCI) and 100 elderly controls (mean age: 75.84; SD: 6.64). Hippocampal traces were converted to parametric surface meshes and a radial atrophy mapping technique was used to compute average surface models and local statistics of atrophy. Surface-based statistical maps visualized links between regional atrophy and diagnosis (MCI versus controls: P = 0.008; MCI versus AD: P = 0.001), mini-mental state exam (MMSE) scores, and global and sum-of-boxes clinical dementia rating scores (CDR; all P < 0.0001, corrected). Right but not left hippocampal atrophy was associated with geriatric depression scores (P = 0.004, corrected); hippocampal atrophy was not associated with subsequent decline in MMSE and CDR scores, educational level, ApoE genotype, systolic or diastolic blood pressure measures, or homocysteine. We gradually reduced sample sizes and used false discovery rate curves to examine the method's power to detect associations with diagnosis and cognition in smaller samples. Forty subjects were sufficient to discriminate AD from normal and correlate atrophy with CDR scores; 104, 200, and 304 subjects, respectively, were required to correlate MMSE with atrophy, to distinguish MCI from normal, and MCI from AD. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19172649      PMCID: PMC2733926          DOI: 10.1002/hbm.20708

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  109 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

Authors:  Liana G Apostolova; Rebecca A Dutton; Ivo D Dinov; Kiralee M Hayashi; Arthur W Toga; Jeffrey L Cummings; Paul M Thompson
Journal:  Arch Neurol       Date:  2006-05

3.  Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease.

Authors:  Yi-Yu Chou; Natasha Leporé; Greig I de Zubicaray; Owen T Carmichael; James T Becker; Arthur W Toga; Paul M Thompson
Journal:  Neuroimage       Date:  2007-12-08       Impact factor: 6.556

4.  Hippocampal morphometry in schizophrenia by high dimensional brain mapping.

Authors:  J G Csernansky; S Joshi; L Wang; J W Haller; M Gado; J P Miller; U Grenander; M I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

5.  Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression.

Authors:  Ian Hickie; Sharon Naismith; Philip B Ward; Keelin Turner; Elizabeth Scott; Philip Mitchell; Kay Wilhelm; Gordon Parker
Journal:  Br J Psychiatry       Date:  2005-03       Impact factor: 9.319

Review 6.  The Alzheimer's disease neuroimaging initiative.

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Neuroimaging Clin N Am       Date:  2005-11       Impact factor: 2.264

7.  Age effects on hippocampal structural changes in old men: the HAAS.

Authors:  Yuan Xu; Daniel J Valentino; Ann I Scher; Ivo Dinov; Lon R White; Paul M Thompson; Lenore J Launer; Arthur W Toga
Journal:  Neuroimage       Date:  2007-12-27       Impact factor: 6.556

8.  Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging.

Authors:  Lei Wang; Jeffrey S Swank; Irena E Glick; Mokhtar H Gado; Michael I Miller; John C Morris; John G Csernansky
Journal:  Neuroimage       Date:  2003-10       Impact factor: 6.556

9.  Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease.

Authors:  G B Frisoni; M P Laakso; A Beltramello; C Geroldi; A Bianchetti; H Soininen; M Trabucchi
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

10.  Influence of education and occupation on the incidence of Alzheimer's disease.

Authors:  Y Stern; B Gurland; T K Tatemichi; M X Tang; D Wilder; R Mayeux
Journal:  JAMA       Date:  1994-04-06       Impact factor: 56.272

View more
  108 in total

Review 1.  Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.

Authors:  Clifford R Jack; Matt A Bernstein; Bret J Borowski; Jeffrey L Gunter; Nick C Fox; Paul M Thompson; Norbert Schuff; Gunnar Krueger; Ronald J Killiany; Charles S Decarli; Anders M Dale; Owen W Carmichael; Duygu Tosun; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 2.  The Alzheimer's disease neuroimaging initiative: progress report and future plans.

Authors:  Michael W Weiner; Paul S Aisen; Clifford R Jack; William J Jagust; John Q Trojanowski; Leslie Shaw; Andrew J Saykin; John C Morris; Nigel Cairns; Laurel A Beckett; Arthur Toga; Robert Green; Sarah Walter; Holly Soares; Peter Snyder; Eric Siemers; William Potter; Patricia E Cole; Mark Schmidt
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

3.  Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume.

Authors:  Owen Carmichael; Jing Xie; Evan Fletcher; Baljeet Singh; Charles DeCarli
Journal:  Neurobiol Aging       Date:  2011-12-14       Impact factor: 4.673

4.  3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.

Authors:  Liana G Apostolova; Kristy S Hwang; John P Andrawis; Amity E Green; Sona Babakchanian; Jonathan H Morra; Jeffrey L Cummings; Arthur W Toga; John Q Trojanowski; Leslie M Shaw; Clifford R Jack; Ronald C Petersen; Paul S Aisen; William J Jagust; Robert A Koeppe; Chester A Mathis; Michael W Weiner; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

5.  3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects.

Authors:  S K Madsen; A J Ho; X Hua; P S Saharan; A W Toga; C R Jack; M W Weiner; P M Thompson
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

Review 6.  Quantitative structural MRI for early detection of Alzheimer's disease.

Authors:  Linda K McEvoy; James B Brewer
Journal:  Expert Rev Neurother       Date:  2010-11       Impact factor: 4.618

Review 7.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

8.  In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRI.

Authors:  John Pluta; Paul Yushkevich; Sandhitsu Das; David Wolk
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

9.  Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Joshua D Grill; Lijie Di; Po H Lu; Cathy Lee; John Ringman; Liana G Apostolova; Nicole Chow; Omid Kohannim; Jeffrey L Cummings; Paul M Thompson; David Elashoff
Journal:  Neurobiol Aging       Date:  2012-04-13       Impact factor: 4.673

10.  Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.

Authors:  Yi-Yu Chou; Natasha Leporé; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Xue Hua; Leslie M Shaw; John Q Trojanowski; Michael W Weiner; Arthur W Toga; Paul M Thompson
Journal:  Neuroimage       Date:  2009-02-21       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.